Novem Group’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Buy
588,288
+67,811
+13% +$1.64M 1.44% 16
2026
Q1
$12.6M Buy
520,477
+109,573
+27% +$2.66M 1.45% 17
2025
Q4
$9.98M Buy
410,904
+24,814
+6% +$603K 1.15% 20
2025
Q3
$9.4M Sell
386,090
-305,715
-44% -$7.41M 1.1% 18
2025
Q2
$16.8M Buy
691,805
+382,674
+124% +$9.23M 2.11% 7
2025
Q1
$7.47M Buy
309,131
+167,728
+119% +$4.03M 1.05% 22
2024
Q4
$3.39M Buy
+141,403
New +$3.4M 0.49% 49

Other funds holding IBDS

Novem Group's IBDS Position: Q2 2026 in Review

Novem Group increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 13% in Q2 2026, buying an estimated $1.64M and bringing the position to 588,288 shares worth $14.2M. The position accounts for 1.44% of the portfolio, ranked #16.

Novem Group first reported a position in IBDS in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.8M in Q2 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Novem Group held 588,288 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $14.2M as of Q2 2026.
  • Novem Group bought 67,811 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $1.64M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 1.44% of Novem Group's portfolio in Q2 2026, its #16 holding.
  • Novem Group first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $16.8M in Q2 2025.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.